Xichun Hu, PhD
Fudan University
4
4
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jian Zhang, PhD
Fudan University
Shared therapeutic areas:
Worked with same sponsors:
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Puma
Biotechnology
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
min yan
Henan Cancer Hospital
Shared therapeutic areas:
Dong Wang, PhD
Daping Hospital & Research Institute of Surgery of the Third Military Medical University
Shared therapeutic areas:
Worked with same sponsors:
Yuankai Shi, Phd
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Zefei Jiang, PhD
Hospital Affiliated to Academy Military Medical Science
Shared therapeutic areas:
Worked with same sponsors:
Xichun Hu, PhD
Medical Oncology Department
Shared therapeutic areas:
Worked with same sponsors:
Kai Li, PhD
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer
Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
All 4 trials loaded